文献速递免疫规划妇幼与学校卫生

泰国孕妇百日咳杆菌抗体血清阳性率及单剂减抗原联合破伤风、白喉和无细胞百日咳疫苗(Tdap)接种后的抗百日咳抗体应答

Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
PubMed 文献 · Vaccine · 2020-02-16

泰国一项随机临床试验纳入129名孕妇,发现抗百日咳毒素IgG血清阳性率为33.3%(43/129)。血清阴性组与血清阳性组接种Tdap后抗体增量无显著差异(30.2 vs. 42 IU/ml;p=0.183)。血清阳性组中,接种Tdap者分娩时抗体均升高,而接种Td者抗体均下降(42 IU/ml vs. -7.4 IU/ml;p<0.001)。

要点

  • 泰国孕妇抗百日咳毒素IgG血清阳性率为33.3%(43/129)。
  • 血清阴性组与血清阳性组接种Tdap后抗体增量无显著差异(p=0.183)。
  • 血清阳性组中接种Tdap者抗体升高,接种Td者抗体下降(p<0.001)。

核心结论

  • 多数泰国孕妇抗百日咳毒素IgG呈血清阴性。
  • 多数血清阳性母亲初始抗体滴度低,且其免疫力在分娩前显著下降。
  • 研究结果强调无论个体基线免疫如何,均需在孕期普遍接种百日咳疫苗。

研究设计与样本

  • 随机临床试验,于2018年4月至2019年4月在泰国曼谷Siriraj医院开展,共纳入129名孕妇。
  • 在首次产前检查及分娩时采集配对血样检测抗PT IgG,基线临界值<5 IU/ml为血清阴性。
  • 从原129名入组者中排除29名;所有血清阴性参与者(n=69)接种Tdap,血清阳性组按1:1随机接种Tdap(n=18)或Td(n=13),于妊娠27-36周接种。

主要发现

  • 孕妇抗PT IgG血清阳性率为33.3%(43/129)。
  • 血清阴性组与血清阳性组接种Tdap后抗体增量无显著差异(30.2 vs. 42 IU/ml;p=0.183)。
  • 血清阳性组中,所有Tdap接种者分娩时抗体滴度均升高,而所有Td接种者整个孕期免疫力下降(42 IU/ml vs. -7.4 IU/ml;p<0.001)。

关键数值与推荐

  • 抗PT IgG基线临界值<5 IU/ml定义为血清阴性。
  • 血清阳性组随机1:1接种Tdap或Td,于妊娠27-36周接种。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal immunization with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) has recently been implemented to prevent infant pertussis. Tdap is still not routinely recommended in Thailand, and there are limited data to support or challenge this strategy. OBJECTIVES: The primary aim was to determine the seroprevalence of anti-pertussis toxin antibodies (anti-PT IgG) among pregnant Thai women. The secondary aims were to evaluate antibodies response after Tdap vaccination between seronegative and seropositive mothers and to compare the different antibody titers at delivery among seropositive mothers who received Tdap to those who received tetanus-diphtheria vaccine (Td). METHODS: This randomized clinical trial was conducted during April 2018 to April 2019 at Siriraj Hospital, Bangkok, Thailand. A total of 129 pregnant women were included. Paired blood samples for anti-PT IgG levels were obtained during the first antenatal visit and at delivery. A baseline cut-off value of <5 IU/ml indicated seronegativity. There were 29 exclusions from the original 129 enrollment. All seronegative participants (n = 69) received Tdap, while the seropositive group were randomized 1:1 to receive either Tdap (n = 18) or Td (n = 13) during 27-36 weeks' gestation. The antibody levels from both sera were compared between groups. RESULTS: The seroprevalence of maternal anti-PT IgG was 33.3% (43/129). There was no significant difference in the increment of antibody levels after Tdap vaccination between the seronegative and seropositive groups (30.2 vs. 42 IU/ml; p = 0.183). Among seropositive groups, all Tdap recipients had increased antibody titers at delivery, while all Td recipients showed waning of immunity throughout gestation. (42 IU/ml vs. -7.4 IU/ml; p < 0.001). CONCLUSION: Most pregnant Thai women have seronegative against pertussis. Most seropositive mothers had initial low antibody titers and their immunity significantly decreased before delivery. Our findings highlight the need for universal pertussis immunization in pregnancy regardless of individual baseline immunity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sompagdee N, Anuwutnavin S, Phongsamart W, et al. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women. Vaccine. 2020. PMID: 32070680. doi:10.1016/j.vaccine.2020.01.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。